Another frequently observed immune evasion mechanism of MIBC is the downregulation of MHC class I (MHCI) presentation on tumor cell membranes in order to evade recognition by cytotoxic T cells; however, MHC-deficient tumor cells can still be recognized and eliminated by NK cells (62–64). The gene discussed is HLA-C; the disease is neoplasm.